Loading search results
Sponsor study identifier
Secondary identifiers
observational
4,429
1 country
18
Study Start
June 28, 2001
Actual (reported)Primary Completion
June 26, 2020
Actual (reported)Study Completion
June 26, 2020
Actual (reported)We will conduct an interdisciplinary case-control/sib-pair study of lung cancer designed to explore the genetic determinants both of lung cancer and of smoking. The study includes biospecimen collection as well as exposure information with power to address main genetic effects and gene-environment interactions. This is an integrated proposal designed to address two major issues: the genetic determinants of lung cancer in smokers and the genetic determinants of smoking. Other important issues will be addressed in the study with a marginal additional cost to the main design. The study achieves excellent power for studying the main effects of genetic factors that are relatively common and good power for formal tests of interactive effects. Using a case-control design, with questionnaire, medical record abstraction, and blood collection, we will investigate: main effects of genes on lung cancer risk; gene-environment and gene-gene effects in lung cancer etiology; gene effects on smoking persistence; gene effects on ever-never smoking; gene-psychological interactions in smoking behaviors. In addition, we will collect viable lymphocytes from all study subjects and tumor, metaplastic and normal tissue samples from 100 surgical cases. With these data and tissues, we will be able to study: genetic instabilities in lung cancer tissue in relation to specific exposures, genotype, persistence of smoking, and clinical presentation of lung cancer; histologic characteristics of lung cancer in relation to genotype, gene expression, somatic mutations, and smoking; functional assays in viable lmphocytes in relation to genotype, gene expression. Finally, we will identify lung cancer-affected siblings of cases, and the unaffected siblings in the same sibships. This sample will permit us to: replicate associations found in the case-control sample with an alternative analytical method based on transmission statistics; address some population stratification issues.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 26, 2020
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 28, 2001
Actual (reported)June 19, 2006
Actual (reported)June 21, 2006
Actual (reported)June 26, 2020
Actual (reported)June 26, 2020
Actual (reported)Tobacco smoking and other exposures and genetic susceptibility measures
Risk of lung cancer
Ongoing
Newly diagnosed lung cancer cases
Population-based controls
Lung cancer cases consecutively enrolled from 13 hospitals and population-based controls with no cancer.
Ospedale Fatebenefratelli Sant'Orsola
Brescia, Italy
Spedali Civili
Brescia, Italy
Azienda Ospedaliera San Paolo
Milan, Italy
Euromedia Marketing Service
Milan, Italy
Fondazione Centro San Raffaele - HSR
Milan, Italy
Hosp Niguarda Ca Granda
Milan, Italy
Istituti Clinici de Perfezionamento ICP
Milan, Italy
Zuber V, Marconett CN, Shi J, Hua X, Wheeler W, Yang C, Song L, Dale AM, Laplana M, Risch A, Witoelar A, Thompson WK, Schork AJ, Bettella F, Wang Y, Djurovic S, Zhou B, Borok Z, van der Heijden HF, de Graaf J, Swinkels D, Aben KK, McKay J, Hung RJ, Bikeboller H, Stevens VL, Albanes D, Caporaso NE, Han Y, Wei Y, Panadero MA, Mayordomo JI, Christiani DC, Kiemeney L, Andreassen OA, Houlston R, Amos CI, Chatterjee N, Laird-Offringa IA, Mills IG, Landi MT. Pleiotropic Analysis of Lung Cancer and Blood Triglycerides. J Natl Cancer Inst. 2016 Aug 26;108(12):djw167. doi: 10.1093/jnci/djw167. Print 2016 Dec.
Yu G, Gail MH, Consonni D, Carugno M, Humphrys M, Pesatori AC, Caporaso NE, Goedert JJ, Ravel J, Landi MT. Characterizing human lung tissue microbiota and its relationship to epidemiological and clinical features. Genome Biol. 2016 Jul 28;17(1):163. doi: 10.1186/s13059-016-1021-1.
Maria T Landi, M.D.
National Cancer Institute (NCI)
4,429 participants (actual enrollment reported by the registry).
First Submitted
June 19, 2006
First Posted
June 21, 2006
Study Start
June 28, 2001
Actual (reported)Contact the study team to confirm eligibility.
L'Azienda Ospedaliera Fatebenefratelli e Oftalmico
Milan, Italy
Ospedale Maggiore di Milano
Milan, Italy
Ospedale San Carlo Borromeo
Milan, Italy
Ospedale San Giuseppe
Milan, Italy
Universita Degli Studi di Milano
Milan, Italy
Azienda Ospedaliera Luigi Sacco
Milan, Italy
Interfield
Milan, Italy
Azienda Ospedaliera San Gerardo
Monza-Milano, Italy
Policlinico San Matteo
Pavia, Italy
Instituto Clinica Humanitas - ICH
Rozzano-Milan, Italy
Azienda Ospedale di Circolo di Varese
Varese, Italy
Shi J, Hua X, Zhu B, Ravichandran S, Wang M, Nguyen C, Brodie SA, Palleschi A, Alloisio M, Pariscenti G, Jones K, Zhou W, Bouk AJ, Boland J, Hicks B, Risch A, Bennett H, Luke BT, Song L, Duan J, Liu P, Kohno T, Chen Q, Meerzaman D, Marconett C, Laird-Offringa I, Mills I, Caporaso NE, Gail MH, Pesatori AC, Consonni D, Bertazzi PA, Chanock SJ, Landi MT. Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study. PLoS Med. 2016 Dec 6;13(12):e1002162. doi: 10.1371/journal.pmed.1002162. eCollection 2016 Dec.
Primary Completion
June 26, 2020
Actual (reported)Study Completion
June 26, 2020
Actual (reported)Last Updated
June 30, 2020
Record last verified: 2020-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: